VGK News 57.44 08/20/2014 05:52:09 Europe ETF FTSE Vanguard

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Europe ETF FTSE Vanguard (VGK) 57.44 $VGK

Are Russian Sanctions Choking European Stocks? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Aug 18, 9:02AM CDT
Should investors who target European ETFs be worries about Russian sanctions?

ETF Issuers Still Favor Euro Zone: Two European Funds Planned - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Aug 15, 7:00AM CDT
Inside some of the latest ETF filings that are targeting the euro zone.

Where Will Europe ETFs Go After Portugal Banking Woes? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 5:00AM CDT
Investors could look at some of the top ranked European ETFs which have declined recently due to Portugal banking woes.

Watch for Vanguard European ETF to Potentially Rebound After Falling 1.28% Yesterday
Comtex SmarTrend(R) - Tue Aug 05, 4:29PM CDT
Vanguard European ETF (AMEX:VGK) traded in a range yesterday that spanned from a low of $56.41 to a high of $57.03. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $56.74 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of Vanguard European ETF to Potentially Rebound after Yesterday's 1.28% Sell Off
Comtex SmarTrend(R) - Tue Aug 05, 4:29PM CDT
Vanguard European ETF (AMEX:VGK) traded in a range yesterday that spanned from a low of $56.41 to a high of $57.03. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $56.74 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Vanguard European ETF Falls 1.97% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Jul 31, 5:20PM CDT
Vanguard European ETF (AMEX:VGK) traded in a range yesterday that spanned from a low of $57.34 to a high of $57.89. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $58.24 on volume of 6.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

2 Great European ETFs to Buy in an Uncertain Market - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 7:00AM CDT
Investors may want to consider these European ETFs for exposure as they are both buy ranked funds.

Buy U.S. Bonds and European Stocks for the Second Half of 2014
at The Street - Fri Jul 18, 5:30AM CDT
Equities in the U.S. look expensive but our debt looks cheap. Overseas it's the exact opposite.

After Yesterday's Decline of 1.05%, Vanguard European ETF Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 07, 4:46PM CDT
Vanguard European ETF (AMEX:VGK) traded in a range yesterday that spanned from a low of $60.05 to a high of $60.28. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $60.25 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of Vanguard European ETF After 1.05% Loss
Comtex SmarTrend(R) - Mon Jul 07, 4:46PM CDT
Vanguard European ETF (AMEX:VGK) traded in a range yesterday that spanned from a low of $60.05 to a high of $60.28. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $60.25 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

ETF Asset Report for the First Half of 2014 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Jul 03, 7:00AM CDT
These ETFs led the way in terms of inflows and outflows for the first half of 2014.

Stock Market Strategists On Defense After Q2 Rise
at Investor's Business Daily - Wed Jul 02, 6:09PM CDT
Despite a flurry of geopolitical turbulence, fund investors enjoyed decent returns in the second quarter of 2014 as the stock market booked a six-quarter winning streak. Investing strategists, however, are positioning themselves defensively in the...

Top ETF Stories of June - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jul 01, 12:00PM CDT
Significant domestic and international developments have attracted investor attention into the ETF world last month. Let's see what these striking stories were.

Vanguard FTSE Europe ETF Experiences Big Inflow
ETFChannel.com - Tue Jul 01, 9:56AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard FTSE Europe ETF where we have detected an approximate $89.9 million dollar inflow -- that's a 0.5% increase...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IBM's Sports Tech Challenge Crowns AI Innovator LivXP

Updated Category News Views 18

Pioneering AI for Fan Engagement The big leagues of sports tech are buzzing, as IBM has just announced LivXP as the standout winner of their Sports Tech Startup Prize Challenge at the dynamic Web Summit Lisbon 2026. If there's one thing to remember, it's that this isn't just any accolade. This is a nod from IBM—an institution that's rubbed elbows with the giants of...

Continue Reading
Skilled Nursing: The Backbone of Comprehensive Care

Updated Category News Views 17

Crucial Crossroads: Hospital to Home Some stories don't come with ticker symbols or stock rises. Sometimes, we're sifting through what really matters—like Terry Esterline's rundown on skilled nursing and rehab services in Hillsdale, Michigan. This isn't about making a quick buck, it's about what helps people rebuild after a hospital stay. The Nuts and Bolts of Skilled...

Continue Reading
Nauticus Schedules 2026 Q3 Earnings Call; Key Insights Await

Updated Category News Views 100

Word on the street is that Nauticus Robotics is gearing up to dish out their third quarter earnings on November 17, 2026. If you're eyeballing the stock, NASDAQ:KITT, this might be your show. Autonomy in the subsea world isn't just about flashy tech—it's about getting investors to buy into the vision. These folks are turning waves into action with robots that perform...

Continue Reading
HLTH 2026: AI's Role in Couples Therapy Unveiled

Updated Category News Views 14

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Continue Reading
DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 266

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Baidu Faces Securities Suit Deadline This Week

Updated Category News Views 74

Deadline Looms Large for Baidu Investors Well, here we are again, dealing with another securities class action. If you've got your money parked in Baidu (NASDAQ:BIDU), the clock is ticking, and it's time to pay attention. November 13, 2026, is creeping up fast, and that could be a serious point of no return. What's the Buzz About? Faruqi & Faruqi, LLP, a heavyweight in...

Continue Reading
FIS Under Investigation: Legal Woes Hit Shareholders

Updated Category News Views 55

When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...

Continue Reading
Millrose Faces Class Action for Alleged Deception

Updated Category News Views 124

A Surprising Turn for Millrose Properties Nobody's grumbling over their coffee as much as Millrose Properties' investors these days. The company, traded under NYSE:MRP, is facing a securities class action lawsuit that'll make even the steeliest fund managers flinch. You see, this isn't just any lawsuit—it's a slap in the face of those who thought they were backing a...

Continue Reading
Frasle Mobility's Resilience Despite Market Woes in 3Q26

Updated Category News Views 125

Economic Wrangling: What Happened? Here comes Frasle Mobility, standing tall against a tide trying to pull everyone under. Ending the third quarter of 2026, they dropped a modest net revenue of R$1.38 billion. A light dip of 1.9% year-over-year, but don't let that fool you. Amid the chaos, these folks managed to expand their gross margin and kept their financials...

Continue Reading
MY DR NOW Challenges 9-to-5 with New Clinics

Updated Category News Views 12

Revolutionizing Healthcare Access Latte in one hand and the other hand tapping your steering wheel, trying to squeeze in that elusive doctor’s appointment between work meetings. Sound familiar? Well, those days might just be numbered. MY DR NOW is shaking up the traditional 9-to-5 doctor’s office stereotype by opening two new clinics that’ll stand sentinel seven...

Continue Reading

Top 5 Most Recently Viewed Articles

Immunocore Unveils Promising Data for Brenetafusp in Ovarian Cancer

Updated Category News Views 129

Immunocore Takes Key Steps with Brenetafusp Immunocore, a biotechnology firm dedicated to creating innovative immunomodulating treatments, has revealed important findings from the Phase 1 trials of brenetafusp, an ImmTAC bispecific that targets PRAME in ovarian cancer patients who are resistant to platinum therapy. These results were shared at a notable medical...

Continue Reading
Santhera and Ikris Pharma Join Forces for AGAMREE® in India

Updated Category News Views 216

Santhera Partners with Ikris for AGAMREE® Distribution Pratteln, Switzerland – Santhera Pharmaceuticals (SIX: SANN) has recently formed a pivotal agreement with Ikris Pharma Network to distribute AGAMREE® (vamorolone) in India. This exclusive partnership is dedicated to providing a treatment option for Duchenne muscular dystrophy (DMD) in children four years and...

Continue Reading
Orchid Island Capital Highlights August Dividend and Portfolio Insights

Updated Category News Views 183

Orchid Island Capital Declares August Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC), a prominent player in the specialized finance sector, has declared a monthly cash dividend of $0.12 per common share for August. This dividend is scheduled for distribution on September 29, keeping with the company’s commitment to returning value to its shareholders. Dividend...

Continue Reading
Mercari Japan App Debuts in U.S.: A Shopping Shift

Updated Category News Views 15

A New Frontier for Cross-Border Shopping There's a fresh wind blowing for collectors and Japan enthusiasts in the U.S. as Mercari Japan rolls out a new standalone app on American soil. Designed to streamline the hunt for Japanese treasures, it’s a bold play to solidify Mercari’s position as a cross-border e-commerce powerhouse. Maybe they’ve seen the writing on the...

Continue Reading
Franklin Access Receives Financing for Groundbreaking Sigbeat Venture

Updated Category News Views 195

Franklin Access Secures New Funding for Innovative Sigbeat Joint Venture Franklin Access (NASDAQ: FKWL) is thrilled to announce that it has successfully secured funding for its strategic joint venture to develop cutting-edge 4G/5G modules and artificial intelligence (AI) solutions under the Sigbeat brand. This significant milestone marks a transformative step towards...

Continue Reading